FDA finds another Indian drugmaker selling contaminated drugs Cadila Pharmaceuticals did not get to source of problems, FDA says November 12, 2014 | By Eric Palmer

Yet another Indian drugmaker has run afoul of the FDA, this one for not doing enough to track down the source of impurities in some products and failing to investigate when customers complained about odors emanating from its APIs.
more